ABSTRACT
With rising melanoma incidence and mortality, early detection and surgical removal of primary lesions is essential. Multispectral imaging is a new, non-invasive technique that can facilitate skin cancer detection by measuring the reflectance spectra of biological tissues. Currently, incident illumination allows little light to be reflected from deeper skin layers due to high surface reflectance. A pilot study was conducted at the University Hospital Basel to evaluate, whether multispectral imaging with direct light coupling could extract more information from deeper skin layers for more accurate dignity classification of melanocytic lesions. 27 suspicious pigmented lesions from 23 patients were included (6 melanomas, 6 dysplastic nevi, 12 melanocytic nevi, 3 other). Lesions were imaged before excision using a prototype snapshot mosaic multispectral camera with incident and direct illumination with subsequent dignity classification by a pre-trained multispectral image analysis model. Using incident light, a sensitivity of 83.3% and a specificity of 58.8% were achieved compared to dignity as determined by histopathological examination. Direct light coupling resulted in a superior sensitivity of 100% and specificity of 82.4%. Convolutional neural network classification of corresponding red, green, and blue lesion images resulted in 16.7% lower sensitivity (83.3%, 5/6 malignant lesions detected) and 20.9% lower specificity (61.5%) compared to direct light coupling with multispectral image classification. Our results show that incorporating direct light multispectral imaging into the melanoma detection process could potentially increase the accuracy of dignity classification. This newly evaluated illumination method could improve multispectral applications in skin cancer detection. Further larger studies are needed to validate the camera prototype.
Subject(s)
Melanoma , Nevus, Pigmented , Skin Neoplasms , Humans , Melanoma/diagnostic imaging , Melanoma/classification , Melanoma/pathology , Melanoma/diagnosis , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/pathology , Skin Neoplasms/classification , Skin Neoplasms/diagnosis , Female , Nevus, Pigmented/diagnostic imaging , Nevus, Pigmented/diagnosis , Nevus, Pigmented/classification , Nevus, Pigmented/pathology , Male , Middle Aged , Adult , Pilot Projects , Aged , Melanocytes/pathology , Lighting/methods , Image Processing, Computer-Assisted/methods , Sensitivity and SpecificityABSTRACT
ABSTRACT: Melanocytic nevi can show a great number of morphological, cytoarchitectural, and stromal variations. Some of these histopathological patterns, infrequent or unusual, can occasionally produce diagnostic doubts or problems. A 22-year-old female patient presented a poorly pigmented cutaneous polypoid lesion of the scalp. Histopathological examination showed an intradermal melanocytic nevus composed of aggregates, nests, and cords of benign melanocytes, with collagenous stroma and large lipomatous areas. In the lipidized portion of the lesion, nevus cells, arranged in clusters, nests, and cords, were intimately associated with mature-appearing adipocytes, CD34-positive spindle cells, Alcian Blue-positive fibromyxoid stroma, and eosinophilic collagen bundles, findings resembling those typically seen in spindle cell lipoma. Spindle cell lipomatous metaplasia, rarely observed in some benign nonmelanocytic skin lesions, can be considered an additional unusual, not previously described, stromal variation occurring in melanocytic nevi.
Subject(s)
Metaplasia , Nevus, Pigmented , Skin Neoplasms , Humans , Female , Metaplasia/pathology , Nevus, Pigmented/pathology , Skin Neoplasms/pathology , Young Adult , Lipoma/pathology , Scalp/pathology , ImmunohistochemistryABSTRACT
Skin diseases manifesting as agminated pigmented lesions have overlapping clinical manifestations. Therefore, accurate differentiation is challenging. The clinical characteristics, histopathological findings, and treatment response of patients diagnosed with partial unilateral lentiginosis, nevus spilus, or linear and whorled nevoid hypermelanosis were retrospectively analysed. Each disease demonstrated distinct demographic and clinical characteristics, and the responses to laser treatment varied. The median age at onset varied significantly among the groups: 0.1, 6.6, and 0.5 years in patients with nevus spilus, partial unilateral lentiginosis, and linear and whorled nevoid hypermelanosis, respectively. Regarding the locations of the skin lesions, partial unilateral lentiginosis occurred predominantly on the head and neck, while approximately half of nevus spilus and linear and whorled nevoid hypermelanosis were observed on the extremities. Although linear and whorled nevoid hypermelanosis and partial unilateral lentiginosis share a similar histological feature of basal hyperpigmentation, patients with linear and whorled nevoid hypermelanosis showed the best response to laser treatment, while patients with partial unilateral lentiginosis demonstrated a poor treatment response. The study's data may provide important clues for the differential diagnosis and clinical decision-making regarding the treatment of these agminated pigmented lesions.
Subject(s)
Hyperpigmentation , Lentigo , Humans , Lentigo/therapy , Lentigo/pathology , Female , Retrospective Studies , Male , Hyperpigmentation/therapy , Hyperpigmentation/pathology , Hyperpigmentation/diagnosis , Treatment Outcome , Child , Infant , Child, Preschool , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Adolescent , Diagnosis, Differential , Nevus, Pigmented/pathology , Nevus, Pigmented/therapy , Adult , Age of Onset , Young Adult , Skin PigmentationSubject(s)
Melanoma , Nevus, Pigmented , Skin Neoplasms , Humans , Nevus, Pigmented/pathology , Nevus, Pigmented/congenital , Skin Neoplasms/pathology , Melanoma/pathology , Female , MaleABSTRACT
Importance: Somatic variants in the RAS/MAPK pathway genes are commonly associated with melanocytic nevi and melanoma, whereas germline variants in these genes are associated with RASopathies, syndromes involving multiple organs, including the skin. Nevi counts may be higher in some RASopathies, but studies on features observed through dermoscopy are limited. Objective: To determine the distinguishing dermoscopic features of melanocytic nevi and how the RAS pathway influences them by comparing nevi in patients with cardiofaciocutaneous syndrome (CFC) and Costello syndrome (CS). Design, Setting, and Participants: In this prospective cohort study, patients with CFC and CS, 2 RASopathies caused by variants in the downstream and upstream components of the RAS/MAPK pathway, were recruited from the international CFC and CS family conferences. Some patients with CFC also elected to participate in a longitudinal follow-up study. Main Outcomes and Measures: The main outcomes were dermoscopic features and, in the longitudinal follow-up study, nevi counts, which were recorded over time. Results: A total of 39 patients, 16 with CFC and 23 with CS, were enrolled (overall cohort: 26 [66.7%] female; median [IQR] age, 13.0 [7.6-22.0] years). The 112 nevi overall frequently displayed an organized dermoscopic pattern (CFC, 61 [84.7%]; CS, 34 [85.0%]) rather than a disorganized pattern (CFC, 6 [8.3%]; CS, 1 [2.5%]). Of the organized nevi, homogenous brown was the most common pattern (CFC, 41 [67.2%]; CS, 22 [64.7%]), followed by reticular (CFC, 11 [18.0%]; CS, 7 [20.6%]) and globular (CFC, 9 [14.8%]; CS, 5 [14.7%]). Pigmented networks occurred in 12 nevi in CFC (16.7%) and 6 nevi in CS (15%; P > .99). Of these, 6 CFC-associated nevi (50%) and no CS-associated nevi had atypical networks (P = .05). Six patients with CFC in the follow-up study developed significantly more nevi within 5 years (median [IQR] increase, 24.5 [10-120] nevi; P = .04). Conclusions and Relevance: In this cohort study, the findings suggest that nevi in patients with CFC and CS commonly display organized homogenous brown dermoscopic patterns, and the number of nevi may significantly increase over time in those with CFC. A disorganized pattern and atypical networks may be more frequent in patients with CFC. Future studies are needed to determine the risk of melanoma in individuals with CFC or CS.
Subject(s)
Costello Syndrome , Dermoscopy , Failure to Thrive , Nevus, Pigmented , Skin Neoplasms , Humans , Nevus, Pigmented/pathology , Nevus, Pigmented/genetics , Nevus, Pigmented/diagnosis , Male , Female , Costello Syndrome/genetics , Costello Syndrome/pathology , Prospective Studies , Skin Neoplasms/pathology , Skin Neoplasms/genetics , Skin Neoplasms/diagnosis , Child , Adolescent , Failure to Thrive/etiology , Young Adult , Follow-Up Studies , Adult , Heart Defects, Congenital/complications , Heart Defects, Congenital/genetics , Heart Defects, Congenital/pathology , Child, Preschool , Facies , Neurocutaneous Syndromes/diagnosis , Neurocutaneous Syndromes/pathology , Neurocutaneous Syndromes/genetics , Cohort Studies , Longitudinal Studies , Ectodermal DysplasiaABSTRACT
ABSTRACT: Close relationship between melanocytes and neural cells is accepted to reflect their common derivation from the neural crest and tumors combining both elements. We present a series of 10 patients with giant congenital melanocytic nevi (CMN) in which a secondary proliferation (11 lesions) with schwannian and/or perineuriomatous differentiation developed in the course of the disease. The age of the patients (4 male and 6 female) at the time of surgery and histological assessment varied from 3 months to 57 years. Histopathologically, the following subgroups were delineated: (1) nodular/tumoriform "neurotization" in CMN, (2) diffuse neurofibroma-like proliferation within CMN, (3) plexiform neurofibroma-like proliferation within CMN, and (4) diffuse perineuriomatous (hybrid schwannomatous-perineuriomatous) differentiation in CMN. We review the pertinent literature, including the role of recently identified Schwann cell precursors which are believed to represent the nerve-associated state of neural crest-like cells that persists into later developmental stages.
Subject(s)
Cell Differentiation , Nevus, Pigmented , Schwann Cells , Skin Neoplasms , Humans , Nevus, Pigmented/pathology , Nevus, Pigmented/congenital , Skin Neoplasms/pathology , Skin Neoplasms/congenital , Male , Female , Infant , Schwann Cells/pathology , Child , Adolescent , Adult , Child, Preschool , Middle Aged , Young AdultABSTRACT
INTRODUCTION: The Preferentially Expressed Antigen in Melanoma (PRAME) immunostain has seen significant diagnostic use in confirming malignancy for melanocytic lesions. However, the expression of PRAME in genital melanocytic lesions have not been reported. In this study, PRAME staining was performed on a cohort of genital melanocytic lesions, aiming to investigate the diagnostic role of PRAME in genital melanocytic lesions and its expression in atypical genital nevi. METHODOLOGY: A cohort including genital invasive melanoma, melanoma-in-situ, atypical genital nevus (AGN), compound nevus, intradermal nevus, blue nevus, lentigo and melanosis was retrieved with histology reviewed and PRAME immunostaining performed. RESULTS: A total of 66 cases were reviewed. The average proportion expression of PRAME were 56.75â¯% and 57.43â¯% for invasive melanoma and melanoma-in-situ, with average H-scores of 153.5/300 and 163.14/300 respectively, which were greater than AGN (3.25â¯%, 7.75/300, p<0.001), compound/intradermal nevi, lentigo/melanosis, and background junctional melanocytes (<1â¯%, <1/300, p<0.001). The different cutoffs of PRAME expression, the sensitivity and specificity were 65.22â¯% and 100â¯% (>100/300); 69.57â¯% and 95.83â¯% (>10/300); and 82.61â¯% and 93.75â¯% (≥1/300) respectively. Low level PRAME expression was seen in half of the cases of AGN (n=2/4, 50â¯%), and at low cutoffs (>10/300 and ≥1/300) unable to differentiate invasive melanoma from AGN (p>0.05). CONCLUSIONS: For genital melanocytic lesions, PRAME immunostain shows high specificity at strong and diffuse staining. AGN not uncommonly display low level expression. Focal and/or weak PRAME expression should not be considered as an absolute indication of malignancy, and comprehensive histological assessment remains the key to accurate diagnosis of melanocytic lesions.
Subject(s)
Antigens, Neoplasm , Biomarkers, Tumor , Melanoma , Skin Neoplasms , Humans , Antigens, Neoplasm/analysis , Antigens, Neoplasm/metabolism , Melanoma/diagnosis , Melanoma/metabolism , Melanoma/pathology , Male , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Skin Neoplasms/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/metabolism , Female , Middle Aged , Adult , Aged , Melanocytes/pathology , Melanocytes/metabolism , Diagnosis, Differential , Nevus, Pigmented/diagnosis , Nevus, Pigmented/pathology , Nevus, Pigmented/metabolism , Young Adult , ImmunohistochemistryABSTRACT
The clinical diagnosis of pigmented genital lesions is challenging. Reflectance confocal microscopy (RCM) is effective for diagnosis but is limited in its application due to elevated costs. A more affordable dermatoscope with a 400x magnification (D400) has recently been brought to market. The aim of our study was to compare these two imaging techniques for the analysis of pigmented genital tumours. An observational, prospective and mono-centric study was carried out from October 2017 to May 2019, in which clinical, dermatoscopic (20x and 400x) and RCM data from 207 pigmented genital lesions were collected. The images generated via D400 and RCM were analysed by three expert investigators. Similarities between the criteria observed using D400 and RCM were evaluated by each investigator. In total, 207 lesions were included: 183 melanosis, 19 nevi, one basal cell carcinoma (BCC), two condylomas and two melanomas in situ. Our series correlates well with data found in the literature especially for the distribution of different lesions, their topography, and their aspect using x20 dermatoscopy and RCM. Pattern and cell criteria defined using RCM largely paralleled those observed with D400 for all three investigators. Correlation between D400 and RCM was moderate to strong with regards to the identification of the ring pattern and clustered round cells, strong for dendritic and plump cells, and perfect for isolated round cells and spindle cells. D400 is an easy-to-use, cost-effective alternative for the analysis of pigmented genital lesions, particularly for melanosis.
Subject(s)
Dermoscopy , Melanosis , Microscopy, Confocal , Skin Neoplasms , Humans , Microscopy, Confocal/methods , Melanosis/diagnostic imaging , Melanosis/pathology , Prospective Studies , Skin Neoplasms/pathology , Skin Neoplasms/diagnostic imaging , Female , Male , Melanoma/diagnostic imaging , Melanoma/pathology , Carcinoma, Basal Cell/diagnostic imaging , Carcinoma, Basal Cell/pathology , Middle Aged , Adult , Condylomata Acuminata/diagnostic imaging , Condylomata Acuminata/diagnosis , Condylomata Acuminata/pathology , Nevus, Pigmented/diagnostic imaging , Nevus, Pigmented/pathology , Aged , Genital Diseases, Female/diagnostic imaging , Genital Diseases, Female/pathology , Nevus/diagnostic imaging , Nevus/pathologyABSTRACT
An 11-year-old female was referred from an outside institution after a diagnostic biopsy and subsequent excision of a progressively enlarging reddish-brown nodule demonstrated features concerning for a balloon cell nevus with severe atypia versus a high-grade melanocytoma. Upon review of the initial biopsy specimen and molecular data, we favored the diagnosis to be consistent with a high-grade melanocytoma with balloon cell changes while considering the possibility of balloon cell melanoma due to concerning histopathologic and genetic abnormalities. In this case study, we discuss critical diagnostic considerations in this rare pediatric case and highlight important pathologic and clinical features of melanocytomas and balloon cell melanoma.
Subject(s)
Melanoma , Nevus, Pigmented , Skin Neoplasms , Humans , Female , Melanoma/diagnosis , Melanoma/pathology , Child , Skin Neoplasms/pathology , Skin Neoplasms/diagnosis , Nevus, Pigmented/pathology , Nevus, Pigmented/diagnosis , Diagnosis, Differential , Melanocytes/pathologyABSTRACT
BACKGROUND: Melanocytic nevi typically appear in early childhood, and their removal is a common plastic surgery procedure performed on children. However, the epidemiological characteristics and hospitalization burden of children with melanocytic nevi have rarely been described in detail. METHODS: Medical records of pediatric inpatients with melanocytic nevi from January 1, 2016, to December 31, 2021, were collected from the Futang Research Center of Pediatric Development database in China. We then extracted and statistically analyzed the relevant information, including demographic characteristics, clinical information, hospitalization burden, and other basic information for each inpatient. RESULTS: Among the 13,396 inpatients with melanocytic nevi, the highest number of cases was found in East China, and most patients were residents of urban areas. Most hospitalized patients consisted of boys aged 7-12 years with melanocytic nevi. Lesion sites in the buttocks and lower limbs were most common among pediatric inpatients with melanocytic nevi. Compound nevi were the most common (38.50 %) histological subtype and the rate of conversion into melanoma was 1.02 % (137 inpatients) among pediatric inpatients with melanocytic nevi. The hospitalization burden for patients varied significantly based on factors such as the age of the patients undergoing surgery, year of hospitalization, site of the lesion, histological subtype, and surgical method. In general, if the patients' age was under 1 year, lesion site was located in face, and there was a need for excision combined with tissue expander can significantly increase the treatment fees for pediatric inpatients with melanocytic nevi. CONCLUSION: Given the increasing number and relatively large hospitalization burden among children with melanocytic nevi hospitalized in China, the government needs to pay more attention to this group and provide corresponding economic and policy support.
Subject(s)
Hospitalization , Nevus, Pigmented , Skin Neoplasms , Humans , Child , Nevus, Pigmented/epidemiology , Nevus, Pigmented/surgery , Nevus, Pigmented/pathology , Male , China/epidemiology , Female , Retrospective Studies , Hospitalization/statistics & numerical data , Hospitalization/economics , Skin Neoplasms/epidemiology , Skin Neoplasms/therapy , Skin Neoplasms/surgery , Skin Neoplasms/pathology , Skin Neoplasms/economics , Child, Preschool , Infant , Adolescent , Cost of Illness , Inpatients/statistics & numerical data , Infant, NewbornSubject(s)
Dermoscopy , Nevus, Pigmented , Skin Neoplasms , Tattooing , Humans , Nevus, Pigmented/pathology , Tattooing/adverse effects , Skin Neoplasms/pathology , Female , Male , AdultABSTRACT
INTRODUCTION: To date, only a limited number of case reports have documented the co-occurrence of PNS and melanocytic nevus in the medical literature. This study aims to report an exceptionally rare case of posterior chest wall PNS in conjunction with a melanocytic nevus. CASE PRESENTATION: A 46-year-old female presented with a long-standing black lesion on her left upper posterior chest wall, that had become painful in the two months prior to presentation. There was a painful, dark blue, non-erythematous, and non-tender nodule on the left upper posterior chest wall. Based on the patient's desire for cosmetic purposes, the lesion was excised totally with primary closure under local anaesthesia. Histopathological examination revealed intradermal melanocytic nevus with inflamed pilonidal sinus. DISCUSSION: The rarity of posterior chest wall PNS associated with nevi poses unique diagnostic and therapeutic challenges for clinicians. The distinct anatomical location, different from the conventional region, and the rare association between the two conditions may delay accurate diagnosis and result in mismanagement or inappropriate interventions. CONCLUSION: The posterior chest wall PNS is another type of atypical PNS that is extremely rare. The association between PNS and blue nevus is a fascinating medical finding that deserves further investigation.
Subject(s)
Nevus, Pigmented , Pilonidal Sinus , Skin Neoplasms , Thoracic Wall , Humans , Female , Middle Aged , Thoracic Wall/pathology , Thoracic Wall/surgery , Pilonidal Sinus/surgery , Pilonidal Sinus/pathology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Nevus, Pigmented/surgery , Nevus, Pigmented/pathology , Nevus, Pigmented/complicationsABSTRACT
This study investigates the differential expression of miRNA gene subtypes in tumoral versus benign nevi in individuals with melanoma, aiming to identify clinically significant correlations that could serve as reliable markers for assessing tumor stage and progression. Conducted between 2019 and 2022, this descriptive, quantitative observational research analyzed 90 formalin-fixed paraffin-embedded (FFPE) samples from the Pius Brinzeu County Emergency Clinical Hospital, Timisoara, including 45 samples of advanced-stage melanoma and 45 samples of pigmented nevi. miRNA purification and analysis were performed using the miRNeasy Kit and the Human Cancer PathwayFinder miScript miRNA PCR Array, with statistical analysis (including logistic regression) to determine associations with cancer staging, such as high Breslow index risk, number of mitoses, and vascular invasion. After the analysis and comparison of 180 miRNA gene subtypes, we selected 10 of the most upregulated and 10 most downregulated genes. The results revealed that hsa-miR-133b, hsa-miR-335-5p, hsa-miR-200a-3p, and hsa-miR-885-5p were significantly upregulated in melanoma samples, with fold changes ranging from 1.09 to 1.12. Conversely, hsa-miR-451a and hsa-miR-29b-3p showed notable downregulation in melanoma, with fold changes of 0.90 and 0.92, respectively. Additionally, logistic regression analysis identified hsa-miR-29b-3p (OR = 2.51) and hsa-miR-200a-3p (OR = 2.10) as significantly associated with an increased risk of a high Breslow index, while hsa-miR-127-3p and hsa-miR-451a were associated with a reduced risk. Conclusively, this study underscores the significant alterations in miRNA expression in melanoma compared to benign nevi and highlights the potential of specific miRNAs as biomarkers for melanoma progression. The identification of miRNAs with significant associations to melanoma characteristics suggests their utility in developing non-invasive, cost-effective diagnostic tools and in guiding therapeutic decisions, potentially improving patient outcomes in melanoma management.
Subject(s)
Biomarkers, Tumor , Disease Progression , Melanoma , MicroRNAs , Humans , Melanoma/genetics , Melanoma/pathology , MicroRNAs/genetics , Male , Female , Middle Aged , Biomarkers, Tumor/genetics , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Aged , Adult , Gene Expression Regulation, Neoplastic , Nevus, Pigmented/genetics , Nevus, Pigmented/pathologyABSTRACT
Tubulin ß-3 staining pattern and staining intensity of 5-hydroxymethyl cytosine (5-hmC) are potential diagnostic and prognostic markers in melanocytic lesions that need further evaluation. Melanocytic nevi and primary cutaneous melanomas were immunohistochemically stained for tubulin-ß-3 and 5-hmC. Immunoreactivity and staining patterns were correlated with Breslow-thickness, clinical and pathological characteristics, and progression-free survival. Melanocytes showed positive tubulin ß-3 staining. However, in most nevi, tubulin ß-3 staining appeared as a gradient with intense cytoplasmic staining in cells of the superficial part of the lesion that faded to weak staining in the deep dermal part, while no gradient was found in deep penetrating nevi and melanomas. In 53 % of the melanomas, areas with loss of tubulin ß-3 staining were found. 5-hmC staining intensity was significantly higher in melanocytic nevi compared to melanomas. Breslow thickness in combination with low 5-hmC score and loss of tubulin-ß-3 staining was predictive for poor prognosis. As single markers, tubulin-ß-3 and 5-hmC can be useful to distinguish between melanocytic nevi and melanoma, but staining variability limits the use of 5-hmC. In melanomas measuring >1.5 mm, combination of low 5-hmC score and loss of tubulin-ß-3 staining may have prognostic value.
Subject(s)
5-Methylcytosine , Biomarkers, Tumor , Melanoma , Skin Neoplasms , Tubulin , Humans , Melanoma/diagnosis , Melanoma/metabolism , Melanoma/pathology , Biomarkers, Tumor/metabolism , Biomarkers, Tumor/analysis , Prognosis , Male , Female , Tubulin/metabolism , Tubulin/analysis , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Skin Neoplasms/metabolism , Middle Aged , 5-Methylcytosine/analogs & derivatives , 5-Methylcytosine/metabolism , 5-Methylcytosine/analysis , Aged , Adult , Immunohistochemistry/methods , Nevus, Pigmented/diagnosis , Nevus, Pigmented/pathology , Nevus, Pigmented/metabolism , Melanoma, Cutaneous Malignant , Aged, 80 and over , Melanocytes/pathology , Melanocytes/metabolismABSTRACT
Melanocytic lesions are instable tumors, the genome of which and its changes determinate their morphology and biological properties. Intermediate lesions share histomorphological features of both, nevi and melanoma. Melanocytomas represent a group of them separated on the basis of recent molecular-biological studies. The article summarizes benign, intermediate, malignant and combined melanocytic skin lesions and offers practical recommendations for diagnosis.